Abstract

Purpose

Indirect immunofluorescence (IIF) on the human epithelial cell-line HEp-2 (or derivatives) serves as the gold standard in antinuclear antibody (ANA) screening. IIF, and its evaluation, is a labor-intensive method, making ANA testing a major challenge for present clinical laboratories. Nowadays, several automated ANA pattern recognition systems are on the market. In the current study, the EUROPattern Suite is evaluated for its use in daily practice in a routine setting.

Methods

A total of 1033 consecutive routine samples was used to screen for ANA. Results (positive/negative ANA screening, pattern identification and titer) were compared between software-generated results (EUROPattern) and visual interpretation (observer) of automatically acquired digital images.

Results

Considering the visual interpretation as reference, a relative sensitivity of 99.3% and a relative specificity of 88.9% were obtained for negative and positive discrimination by the software (EPa). A good agreement between visual and software-based interpretation was observed with respect to pattern recognition (mean kappa: for 7 patterns: 0.7). Interestingly, EPa software distinguished more patterns per positive sample than the observer (on average 1.5 and 1.2, respectively). Finally, a concordance of 99.3% was observed within the range of 1 titer step difference between EPa and observer.

Conclusions

The ANA IIF results reported by the EPa software are in very good agreement with the results reported by the observer with respect to being negative/positive, pattern recognition and titer, making automated ANA IIF evaluation an objective and time-efficient tool for routine testing.

Details

Title
Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting
Author
van Beers Joyce J B C 1   VIAFID ORCID Logo  ; Hahn, Melanie 2 ; Fraune Johanna 2 ; Mallet, Kathleen 1 ; Krause, Christopher 2 ; Hormann Wymke 2 ; Fechner Kai 2 ; Damoiseaux Jan G M C 1 

 Maastricht University Medical Center, Central Diagnostic Laboratory, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382) 
 Institute for Experimental Immunology, EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany (GRID:grid.428937.3) 
Publication year
2018
Publication date
Dec 2018
Publisher
Springer Nature B.V.
ISSN
2038-0305
e-ISSN
2038-3274
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2427371784
Copyright
© The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.